Worldwide Hospital Acquired Disease Testing Industry to 2026 – Featuring Alere, bioMerieux and Hologic Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hospital Acquired Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added to ResearchAndMarkets.com’s offering.

The global hospital-acquired disease testing market reached a value of US$ 7.32 Billion in 2020. Hospital acquired infections (HAIs) or nosocomial infections are diseases that are acquired in hospitals and medical clinics. Nosocomial means, infections or diseases originating in a hospital. A person can get such diseases even in the vicinity of a nursing home, rehabilitation center, hospital or any other clinical surroundings. Most people get HAIs when they are in intensive care units (ICUs) and the emergency rooms (ERs). Generally, the incubation period of these diseases vary between 48 hours to 4 days after the individual gets admitted.

A major reason behind the cause of hospital acquired diseases is the lack of proper hygiene in the hospital settings by the internal staff. Another reason can be below-par maintenance, complacency by the hospital staff, and a rise in multi-drug resistant organisms (MDROs). Some of the most commonly occurring nosocomial infections include pneumonia, primary bloodstream infections, urinary tract infections, etc. In many cases, it has also been found that these nosocomial infections are sometimes traced to the patients’ own microbiome. It happens when the protective skin layer comes in contact with possible threats and causes infection to occur, especially after surgical operations.

The market for hospital acquired disease testing is currently exhibiting double digit growth rates. Catalyzed by rising population and modernization of the healthcare infrastructure, there has been a significant increase in the number of health care facilities across the globe. This has resulted in a rising incidence of HAIs, driving the demand of hospital acquired disease tests. Moreover, with advanced technologies and scientific innovations, various techniques are now available in the market for preventing, diagnosing, and monitoring HAIs such as microarrays, polymerase chain reaction (PCR), real time location systems (RTLSs), and solid phase hybridization. Techniques such as RTLS makes it easy to prevent HAIs from spreading in both patients and staff. Growing awareness of HAIs among patients and governments enacting regulations that penalize hospitals having a high incidence of HAIs are some of the other factors that are catalyzing the growth of the market. Looking forward, the publisher expects the global hospital acquired disease testing market to exhibit strong growth during the next five years.

Based on the indication, the market has been segmented into urinary tract infection, surgical site infection, pneumonia, bloodstream infections, methicillin-resistant staphylococcus aureus and others. Urinary tract infection currently represents the biggest segment.

Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Companies Mentioned

• Abbott Laboratories
• Alere Inc
• Becton Dickinson Company
• bioMerieux SA
• F. Hoffmann-La Roche Ltd.
• Hologic Inc
• QIAGEN
• Siemens Healthcare
• Diatherix Laboratories Inc
• Meridian Bioscience Inc
• Thermo Fisher Scientific Inc (Life Technologies Corporation)
• Cepheid Inc

This report provides a deep insight into the global hospital-acquired disease testing market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the hospital-acquired disease testing market in any manner.

Key Questions Answered in This Report:

1. What is the market size for the global hospital acquired disease testing market?

2. What is the global hospital acquired disease testing market growth?

3. What are the global hospital acquired disease testing market drivers?

4. What are the key industry trends in the global hospital acquired disease testing market?

5. What is the impact of COVID-19 on the global hospital acquired disease testing market?

6. What is the global hospital acquired disease testing market breakup by indication?

7. What are the major regions in the global hospital acquired disease testing market?

8. Who are the key companies/players in the global hospital acquired disease testing market?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Hospital Acquired Disease Testing Market

6 Market Breakup by Indication

7 Market Breakup by Region

8 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/9bfvk9

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900